12.07.2015 Views

Cognitive-Behavioral Body Image Therapy for Body Dysmorphic ...

Cognitive-Behavioral Body Image Therapy for Body Dysmorphic ...

Cognitive-Behavioral Body Image Therapy for Body Dysmorphic ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BODY DYSMORPHIC DISORDER 267Table 1Means and Standard Deviations of Dependent Variables by Treatment Phase<strong>Cognitive</strong>-behaviortherapy(n = 27)'No treatment(n = 27)MeasureMSDMSD<strong>Body</strong> <strong>Dysmorphic</strong> Disorder ExamPretreatmentPosttreatmentFollow-upMBSRQ Appearance Evaluation ScalePretreatmentPosttreatmentFollow-up<strong>Body</strong> Shape QuestionnairePretreatmentPosttreatmentFollow-upBrief Symptom InventoryPretreatmentPosttreatmentFollow-upRosenberg Self-Esteem ScalePretreatmentPosttreatmentFollow-up83.941.139.91.973.082.99133.587.588.0.92.57.5025.129.930.014.816.921.3.42.59.8219.220.422.8.48.46.405.65.65.2Note. MBSRQ = Multidimensional <strong>Body</strong> Self-Relations Questionnaire.• At follow-up, N = 26.89.983.2—1.861.85—142.7142.4—1.01.0—23.924.9—16.119.7—.39.59—24.626.3—.53.60—4.75.9—nificant main effects <strong>for</strong> time <strong>for</strong> each variable (df= 2,49; p =.000): <strong>Body</strong> <strong>Dysmorphic</strong> Disorder Examination, F(2, 49) =69.02, p = .000; MBSRQ Appearance Evaluation Scale, F(2,49)= 31.89, p = .000; <strong>Body</strong> Shape Questionnaire, F( 2,49) = 57.55,p = .000; psychological symptoms, F(2, 49) = 17.59, p = .000;and self-esteem, F(2,49) = 28.23, p = .000.Post hoc paired comparisons controlling <strong>for</strong> family-wise errorindicated that treatment subjects improved significantly onall measures from pre- to posttreatment and pretreatment tofollow-up at p = .000, except that the pre- to posttreatmentchange in psychological symptoms was significant at p = .003.There were no significant differences between posttreatmentand follow-up.Rates of Clinically Significant ImprovementTo be considered clinically improved, a subject had to (a)no longer meet the diagnostic criteria on the <strong>Body</strong> <strong>Dysmorphic</strong>Disorder Examination and (b) have a score lower on the BDDEafter treatment than her pretreatment score minus 2 standarderrors of measurement. Using Speer's recommendation <strong>for</strong> calculatingclinically significant change (1992), we centered thisconfidence interval on an estimate of the subject's "true" pretreatmentscore, which adjusted <strong>for</strong> regression to the mean. Twosubjects in the no-treatment condition (7.4%) met these criteria<strong>for</strong> improvement after the waiting period. Of the 27 cognitivetherapy subjects, 22 were clinically improved at posttreatment(81.5%) and 20 of 26 were improved at follow-up (76.9%).Three of the five unimproved treatment subjects at posttreatmentwere clinically improved at follow-up, and four "relapsed,"that is, no longer scored in the clinically improvedrange at follow-up.Discussion<strong>Cognitive</strong> behavioral body image therapy proved to be aneffective treatment <strong>for</strong> body dysmorphic disorder. The total severityof BDD symptoms of therapy subjects decreased to thenormal range on the <strong>Body</strong> <strong>Dysmorphic</strong> Disorder Examination(.4 SD above the mean <strong>for</strong> a community sample, Rosen &Reiter, 1993) and the majority of patients no longer met thediagnostic criteria <strong>for</strong> BDD. Preoccupation with appearanceand body dissatisfaction were improved on the other two measuresof body image, the <strong>Body</strong> Shape Questionnaire andMBSRQ Appearance Evaluation scale. The means on thesescales decreased from the clinically severe range to the normalrange. Although other psychological symptoms were nottargeted in therapy, on average the total severity of symptomsand global self-esteem improved to the normal range.Treatment was not uni<strong>for</strong>mly effective; a significant minorityof subjects still had BDD at the follow-up. We were unable toidentify any subject characteristics that distinguished these patientsfrom others. They did not differ in demographics or severityof body image and psychological symptoms at baseline.However, in regard to the therapy <strong>for</strong>mat, our impression wasthat some patients might have benefitted from longer treatmentand more intensive, supervised exposure response preventionoutside of the clinic. Also, it is possible that some subjects might

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!